IL17A and systemic lupus erythematosus: However, Schmidt et al. showed that IL-17A deficiency had no effect on the clinical course of lupus-prone MRL/lpr mice and NZB/NZW mice, but anti-IFN-γ treatment attenuated the severity of the LN [33].